The largest database of trusted experimental protocols

19 protocols using phr sffv krab dcas9 p2a mcherry

1

CRISPR-Cas9 Transcriptional Repression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
sgRNA sequences (Supplementary Table 4) were cloned into the pLG1 plasmid (gift from Prof. Jonathan Weissman). Intact pLG1 plasmid that contains sgRNA sequence against EGFP gene was also used as a negative control. sgRNA containing pLG1 vectors along with the pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene, plasmid #60954) were used to generate lentivirus using the Lenti-Pac HIV expression packaging kit (GeneCopoeia). Lentivirus was concentrated using the Lenti-X Concentrator (Takara). mHypoA-POMC/GFP-1 cells were infected with sgRNA and KRAB-dCas9 virus (1:1 ratio) at a multiplicity of infection (MOI) of 0.5. Following 48 hours, RNA was extracted using the RNeasy mini kit (Qiagen) and reverse-transcribed using Superscript III reverse transcriptase (Invitrogen). Gene expression was examined by RT-qPCR using SSO fast EvaGreen supermix (Bio-Rad) was carried out on an Eppendorf Realplex 2. Primers used for the qPCR are shown in Supplementary Table 4.
+ Open protocol
+ Expand
2

CRISPR-Mediated LTR Silencing in Leukemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
sgRNAs (Sigma-Aldrich) targeting multiple LTR copies were cloned into lentiviral expression vector pKLV-U6gRNA(BbsI)-PGKpuro2ABFP (Addgene 50946, deposited by K. Yusa). For LTR silencing, OCI-AML3 and K562 cells were first transduced with the lentiviral vector pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene 60954, deposited by Jonathan Weissman), sorted for mCherry on a FACSAria II. Cells expressing mCherry were then subsequently transduced with the lentiviral sgRNA expression vector. Two days later, the cells expressing both mCherry and BFP were sorted and cultured for transcriptional and chromatin analyses.
+ Open protocol
+ Expand
3

Engineered Lentiviral Vectors for CRISPR/Cas9 Genome Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sgRNA vector (pLenti-sgRNA-GFP) was cloned by replacing the U6 promoter in pLL3.7 (Addgene) with the human U6 promoter, ccdB cassette, and sgRNA scaffold. The Cas9 expression vector (pLenti-OC-IRES-BSD) has been previously reported [8 (link)]. pcDNA-HBEGF and pcDNA-PSMB5 were cloned by replacing the KRAB-dCas9 element of pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene) with the human HBEGF or PSMB5 coding sequence and 3×FLAG. Vectors expressing cDNA of HBEGF with single-a.a. deletions were constructed via PCR-based site-directed mutagenesis (PfuUltraII Fusion HS DNA Polymerase, STRATAGENE). The primers used for these purposes are listed in Additional file 5: Table S7. Vectors expressing cDNAs of PSMB5 M104 and V90 substitutions were constructed via PCR-based site-directed mutagenesis (PrimeSTAR HS DNA Polymerase, Takara). Primers used for the construction of M104 and V90 substitution mutants are listed in Additional file 5: Table S10.
+ Open protocol
+ Expand
4

Targeted Gene Regulation in Neural Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
sgRNA sequences for BARHL1, IRX3, LHX5, OTX1, OTX2, and PAX6 promoters were cloned into pLG1 as described above. sgRNA plasmids and pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene, #60954, RRID:Addgene_60954) were co-packaged and transduced into H1 hESCs via lentivirus at a MOI of 5 along with 8 μg/mL polybrene (Sigma). Cells were incubated for 2 days to allow genomic integration and further cultured for 2 days in mTeSR media supplemented with 2 μg/mL puromycin for selection. At day 4 after infection, the cells were replated and cultured in mTeSR supplemented with puromycin. At day six, cells were induced into a neural lineage by dual-Smad inhibition. At day 9 and 12 (72 hours and 6 days post neural induction), total RNA was collected using RNeasy mini kit (QIAGEN) and reverse-transcribed using SuperScript III first-strand synthesis system (Invitrogen). qPCR was performed using SsoFast EvaGreen supermix (Bio Rad) according to the manufacturer’s protocol. sgRNA sequences and primers used for the plasmid construction and RT-qPCR are shown in Table S7, sheet 5.
+ Open protocol
+ Expand
5

CRISPR-Cas9 Transcriptional Repression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
sgRNA sequences (Supplementary Table 4) were cloned into the pLG1 plasmid (gift from Prof. Jonathan Weissman). Intact pLG1 plasmid that contains sgRNA sequence against EGFP gene was also used as a negative control. sgRNA containing pLG1 vectors along with the pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene, plasmid #60954) were used to generate lentivirus using the Lenti-Pac HIV expression packaging kit (GeneCopoeia). Lentivirus was concentrated using the Lenti-X Concentrator (Takara). mHypoA-POMC/GFP-1 cells were infected with sgRNA and KRAB-dCas9 virus (1:1 ratio) at a multiplicity of infection (MOI) of 0.5. Following 48 hours, RNA was extracted using the RNeasy mini kit (Qiagen) and reverse-transcribed using Superscript III reverse transcriptase (Invitrogen). Gene expression was examined by RT-qPCR using SSO fast EvaGreen supermix (Bio-Rad) was carried out on an Eppendorf Realplex 2. Primers used for the qPCR are shown in Supplementary Table 4.
+ Open protocol
+ Expand
6

Lentiviral-mediated Gene Manipulation in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The shRNAs were cloned into the pLKO.1-puro vector (Addgene, #8453) by following the manufacturer’s instructions. The targeting sequence of each shRNA was listed in Supplementary Data 3. MSCV-Myc-IRES-RFP (Addgene,#35395) and pCDH-puro-cMyc (Addgene,#46970) were used to expression MYC in the rescue experiments in mouse and human cell lines, respectively. For CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) experiments, gRNAs were cloned into the LentiGuide-Puro (Addgene#52963) vector by using the BsmBI site. pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene#60954) was used to express the dCas9-KRAB fusion protein. Sequences for all the sgRNAs were listed in Supplementary Data 3.
+ Open protocol
+ Expand
7

Regulation of CCND1 by Superenhancer Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene) and Lenti_MCP-LSD1_Hygro (Addgene) were packaged into a slow-replicating virus. After transducing Huh7 cells with both viral vectors, we selected hygromycin-resistant and mCherry-positive cells to finally obtain the corresponding dCas9-KRAB-LSD1 cells. Next, based on the H3K27ac ChIP-seq and ATAC-seq peaks in Huh7 cells, we found the location of the superenhancer and obtained the DNA sequences of the corresponding ATAC-seq peaks. The sgRNAs used to inhibit the superenhancers were designed with CRISPR-ERA (http://crispr-era.stanford.edu/). Annealed double-stranded DNA was inserted into Lenti_sgRNA(MS2)_ZsGreen1 (Addgene) using BsmI (NEB). Then, viruses packaged with the purified recombinant plasmid were used to infect dCas9-KRAB-LSD1 cells in 6-well plates. After screening of ZsGreen-positive cells using flow cytometry, the variation in the mRNA level of CCND1 was obtained using qPCR. Primer sequences are listed in Supplementary Table S1.
+ Open protocol
+ Expand
8

KRAB-dCas9 Plasmid Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ZFP3 sequence recognizing CGAGCCCTCAGATGC was synthesized by Genescript (NJ, USA). It was cloned into the plasmid pHR-SFFV-KRAB-dCas9-P2A-mCherry by substitution of KRAB-dCas9 cassette using Gibson assembly (New England Biolabs, Cat#E2611). Later the mCherry was substituted with BFP [50 (link)]. Primers for Gibson assembly are found in S2 Table. pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene plasmid #60954) and pU6-sgRNA-EF1Alpha-puro-T2A-BFP (Addgene plasmid #60955) were gifts from Jonathan Weissman. Guide RNAs for dCas9 were cloned into the pU6-sgRNA-EF1Alpha-puro-T2A-BFP plasmid.
+ Open protocol
+ Expand
9

CRISPR-Mediated Silencing of IRF1 Enhancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The single guide (sg) RNAs were designed for IRF1 target regions using CHOPCHOP (http://chopchop.cbu.uib.no). A human genome non-targeting gRNA was used as a negative control. Synthesized oligonucleotides (Integrated DNA Technologies) were annealed and cloned into the Esp3I restriction sites of lentiviral expression vector Lenti_sgRNA_EFS_GFP (Addgene plasmid # 65656 (38 (link))). Sanger sequencing confirmed sgRNAs insertion. The gRNA target sequences are non-targeting, 5’-GTTCCGCGTTACATAACTTA-3’, and IRF1 enhancer targeting, 5’- TCGGCGCGCAGGCACTCAGA-3’.
Lentivirus was produced in HEK293FT cells used to transduce target cells in the presence of 4 µg/mL polybrene (Sigma). For IRF1 Enhancer silencing, hSAECs were first transduced with the lentiviral vector pHR-SFFV-KRAB-dCas9-P2A-mCherry (Addgene plasmid # 60954 (38 (link))). The vector expresses a fusion protein of mammalian codon-optimized Streptococcus pyogenes dCas9 (DNA 2.0) fused at the N terminus with the Kox1 KRAB domain and two SV40 nuclear localization sequences at the C terminus. mCherry-expressing hSAECs were transduced with the lentiviral sgRNA expression vector. Two days later, the dual mCherry and GFP-expressing cells were sorted and cultured for RSV infection experiments.
+ Open protocol
+ Expand
10

CRISPRi-mediated Enhancer/Promoter Repression

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa SCC1-mEGFP-AID cells stably expressing dCas9-KRAB for CRISPRi-mediated repression of enhancer or promoter activity were generated by transduction with the lentiviral vector pHR-SFFV-KRAB-dCas9-P2A-mCherry (Gilbert et al., 2014 (link)) (Addgene plasmid #60954) and subsequent sorting for mCherry-positive cells using a FACS Aria III cell sorter (BD Lifesciences). Lentiviral packaging was performed in Lenti-X packaging cells (Takara Bio) transfected with lentiviral transfer plasmids and packaging plasmids helper plasmids pCMV-VSV-G (Addgene plasmid #8454) and pCMVR8.74 (Addgene plasmid #22036) using standard procedures. gRNA oligos (sequences in Table S3A) were cloned into pETN expression vector (Michlits et al., 2020 (link)) and transfected into packaging cells (293FT, Thermo Fisher, R70007) using Fugene 6 (Promega, E2691). Virus was then harvested and applied to Scc1-EGFP-AID/dCas9-KRAB cells. Infected cells were selected by G418 (GIBCO, 108321-42-2) and used for RT-qPCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!